Using a Mathematical Model to Demonstrate the Effect of Variations in Immune Response Efficacy on Optimal Antibiotic Treatment Strategies for an Acute Bacterial Infection. (4th October 2017)
- Record Type:
- Journal Article
- Title:
- Using a Mathematical Model to Demonstrate the Effect of Variations in Immune Response Efficacy on Optimal Antibiotic Treatment Strategies for an Acute Bacterial Infection. (4th October 2017)
- Main Title:
- Using a Mathematical Model to Demonstrate the Effect of Variations in Immune Response Efficacy on Optimal Antibiotic Treatment Strategies for an Acute Bacterial Infection
- Authors:
- Ankomah, Pierre
- Abstract:
- Abstract: Background: While well-recognized that clearance of bacterial infections occurs through a collaboration between antibiotics and the immune system, existing strategies for evaluating optimal antibiotic treatment regimens, including pharmacodynamic/pharmacokinetic assessments and mathematical/computer simulation models, have been limited in their consideration of the immune response and variations therein. Methods: This study develops a within-host mathematical model of an acute, potentially self-limiting bacterial infection and utilizes it to explore antibiotic dose regimens under conditions of varying immune response efficacy by comparing a normal response that would clear the infection to: (i) a hypoactive/suppressed, and (ii) a hyperactive/dysfunctional immune response, to examine how different regimens affect time to clearance of the infection, as well as de novo generation of antibiotic-resistant populations and the ascent of populations that exist prior to treatment initiation. Results: Numerical analyses of the model demonstrate that there are threshold antibiotic doses required to mitigate the immunologic deficits of the abnormal immune responses to allow for clearance of the infection and decrease the likelihood of resistance evolving. Treating with low doses fosters the generation of high-level antibiotic-resistant populations at all levels of immune efficacy. However, more moderate dosing regimens can slow the rate of ascent of pre-existing-resistantAbstract: Background: While well-recognized that clearance of bacterial infections occurs through a collaboration between antibiotics and the immune system, existing strategies for evaluating optimal antibiotic treatment regimens, including pharmacodynamic/pharmacokinetic assessments and mathematical/computer simulation models, have been limited in their consideration of the immune response and variations therein. Methods: This study develops a within-host mathematical model of an acute, potentially self-limiting bacterial infection and utilizes it to explore antibiotic dose regimens under conditions of varying immune response efficacy by comparing a normal response that would clear the infection to: (i) a hypoactive/suppressed, and (ii) a hyperactive/dysfunctional immune response, to examine how different regimens affect time to clearance of the infection, as well as de novo generation of antibiotic-resistant populations and the ascent of populations that exist prior to treatment initiation. Results: Numerical analyses of the model demonstrate that there are threshold antibiotic doses required to mitigate the immunologic deficits of the abnormal immune responses to allow for clearance of the infection and decrease the likelihood of resistance evolving. Treating with low doses fosters the generation of high-level antibiotic-resistant populations at all levels of immune efficacy. However, more moderate dosing regimens can slow the rate of ascent of pre-existing-resistant populations, particularly when immune responses are suboptimal. Conclusion: This study demonstrates the effect of variations in immune response on optimal antibiotic treatment regimens that maximize rate of infection clearance and minimize the likelihood of resistance evolution in acute, potentially self-limiting infections. It illustrates the importance of incorporating quantitative immunological assessments into evaluations of antibiotic treatment regimens. Disclosures: All authors: No reported disclosures. … (more)
- Is Part Of:
- Open forum infectious diseases. Volume 4(2017)Supplement 1
- Journal:
- Open forum infectious diseases
- Issue:
- Volume 4(2017)Supplement 1
- Issue Display:
- Volume 4, Issue 1 (2017)
- Year:
- 2017
- Volume:
- 4
- Issue:
- 1
- Issue Sort Value:
- 2017-0004-0001-0000
- Page Start:
- S291
- Page End:
- S291
- Publication Date:
- 2017-10-04
- Subjects:
- Communicable diseases -- Periodicals
Medical microbiology -- Periodicals
Infection -- Periodicals
616.9 - Journal URLs:
- http://ofid.oxfordjournals.org/ ↗
http://www.oxfordjournals.org/en/ ↗ - DOI:
- 10.1093/ofid/ofx163.661 ↗
- Languages:
- English
- ISSNs:
- 2328-8957
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21307.xml